期刊文献+

顺铂及顺铂载体的研究进展 被引量:24

Research evolution of cisplatin antitumor drugs and cisplatin-loaded
下载PDF
导出
摘要 本文探讨抗肿瘤药顺铂的临床特点及其研究进展,为临床应用提供参考。通过查阅国内外相关文献,系统地了解抗肿瘤药顺铂的临床作用,剂量限制性毒性及耐药性,并检索未获批准及正在进行临床研究的顺铂载体,以分析其临床发展趋势。在过去的10年间,药物研发转向注重药物运输靶向介质,这些新型载体在保留传统顺铂的活性的同时,在很大程度上减少了传统铂类药物的不良反应,提高疗效。 This article discussed the clinical features and research progress of cisplatin antitumor drugs for clinical references in drug application. The related literature both domestic and overseas was reviewed for a systematic understanding of the clinical effects and dose-limitted-toxicity and drug-resistance of cisplatin antitumor drugs. The cisplatin antitumor drugs,including those unapproved ones and those ongoing clinical trials were retrieved for analysis of their development tendency in the clinic. During the last decade, the focus of research and development on cisplatin has been shifted to targeted drug delivery system. These new cisplatin-loaded has the activity of cisplatin compound yet with greatly reduced side effects observed with traditional cisplatin drugs and enhance the efficiency.
出处 《中国当代医药》 2011年第22期25-27,共3页 China Modern Medicine
关键词 顺铂 剂量限制性毒性 耐药性 顺铂脂质体 纳米粒子 Cisplatin Dose-limitted-toxicity Drug-resistance Lipoplatin Nanoparticles
  • 相关文献

参考文献16

二级参考文献108

  • 1韩克,江森,孙树三,乔乃安,章晓梅,郭玲玲,王美清,乔柏生,刘文军,邹立家,赵炎,张磊.卡铂多相脂质体腹腔注射对615小鼠U_(14)移植瘤腹膜后淋巴结和肺转移的抑制作用[J].现代妇产科进展,1995,4(2):112-115. 被引量:3
  • 2马晶,邓树海.顺铂前体脂质体的制备及包封率测定[J].中国医院药学杂志,2006,26(4):416-418. 被引量:4
  • 3孙润广,张静,王永昌.亚油酸铂靶向脂质体抗肿瘤特性的研究[J].生物物理学报,1996,12(3):419-427. 被引量:9
  • 4宋现让,魏玲,王兴武,郑燕,柳永蕾.18种人肿瘤细胞株药物敏感性与基因表达的关系[J].中国现代医学杂志,2006,16(16):2474-2477. 被引量:3
  • 5[3]Burger AM, Double JA, Newell DR. Inhibition of telomerase activity by cisplatin in human testicular cancer cells. Eur J Cancer,1997,33(4)∶638-644.
  • 6[5]Reddy VG, Khanna N, Singh N. Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing p53. Biochem Biophys Res Commun,2001,282(2)∶409-415.
  • 7[6]Misawa M, Tauchi T, Sashida G, et al. Inhibition of human telomerase enhances the effect of chemotherapeutic agents in lung cancer cells. Int J Oncol,2002,21(5)∶1087-1092.
  • 8[7]Finkel E. Telomerase: keys to senescence and cancer. Lancet,1998,351(9110)∶1186-1195.
  • 9[9]Faraoni I, Turriziani M, Masci G, et al. Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro. Clin Cancer Res,1997,3(4)∶579-585.
  • 10[10]Shiroko T, Saji S, Kawaguchi Y, et al. A study on the relationship between clinicopathological findings of gastric cancer and its biological behavior such as DNA ploidy pattern and immunohistochemical staining of PCNA, laminin, p53 and nm23. Gan To Kagaku Ryoho,1995,22(Suppl 2)∶118-123.

共引文献55

同被引文献259

引证文献24

二级引证文献141

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部